Back to results
US 2024/0002799 A1Published application
Method for generating human dendritic cells for immunotherapy
AssigneeThe Regents of the University of California
InventorsChristopher S. SEET, Gay Miriam CROOKS
Life of this patent
Estimating the term…
Abstract
In various embodiments methods of producing a cell population enriched for CLEC9A+ dendritic cells are provided where the methods involve culturing stem cells and/or progenitor cells in a cell culture comprising culture medium, a notch ligand, stem cell factor (SCF), FLT3 ligand (FLT3L); thrombopoietin (TPO); and IL-3 and/or GMCSF.
Claims19
1-92. (canceled)
A method of preparing a dendritic cell vaccine for a subject, said method comprising:
- preparing a cell population enriched for CLEC9A+ dendritic cells;
- and
- pulsing or loading said dendritic cells with a tumor cell antigen, a tumor cell lysate or tumor cell preparation,
- wherein said cell population enriched for CLEC9A+ dendritic cells is produced by a method comprising co-culturing stem cells or progenitor cells with stromal cells transduced or transfected with a nucleic acid that encodes and expresses a notch ligand,
- wherein the notch ligand is DLL4, DLL1, Jagged 1 (JAG1), or Jagged 2 (JAG2), or a Notch-binding fragment of DLL4, DLL1, Jagged 1 (JAG1), or Jagged 2 (JAG2),
- wherein said co-culturing comprises culture medium supplemented with L-alanyl-L-glutamine dipeptide.
3 more elements
Dependencies are inferred from the claim text.